Orylmyte (Dermatophagoides Pteronyssinus, Dermatophagoides Farinae)

Dermatophagoides pteronyssinus and Dermatophagoides farinae, the active ingredients in Orylmyte, are allergen extracts used in sublingual immunotherapy presented as a sublingual tablet for oral use. It is intended to modify immune responses to house dust mite allergens in sensitised individuals. GNH USA supplies Orylmyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orylmyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orylmyte is a sublingual immunotherapy product that targets allergic disease pathways.

- Allergic rhinitis: reduces nasal congestion, sneezing and itching associated with house dust mite sensitivity. - Allergic asthma: helps lower bronchial hyper‑responsiveness and reliance on rescue inhalers in mite‑sensitized patients. - Oral allergy syndrome: may lessen oral itching and swelling after exposure to cross‑reactive foods in dust‑mite allergic individuals.

The                 ... ... ... ...  …  ... … ... ... ... … ... ...

...